Consistent with these results, immunohistochemistry (IHC) staining assay revealed elevated PTPN2 expression in ALK‐positive tumor cells from the lymph node tissues of 8 ALK+ ALCL patients (Figure 1F), with detailed clinical characteristics summarized in Table S2 (Supporting Information). This evidence concerns the gene PTPN2 and neoplasm.